Media coverage
4
Media coverage
Title Ophirex Publishes Phase 2 Data in BMJ Global Health from the First Use of Varespladib to Treat Venomous Snakebite Victims Media name/outlet Business Wire Country/Territory United States Date 23/10/24 URL ct.moreover.com/?a=55100639743&p=1gw&v=1&x=U4Jtw2tkYxHeBi3mVgMJvw Persons Charles Gerardo Title Ophirex Publishes Phase 2 Data in BMJ Global Health from the First Use of Varespladib to Treat Venomous Snakebite Victims; Efficacy signal observed in subgroup of victims treated within five hours of bite reinforces critical importance of timely treatment Media name/outlet Business Wire Country/Territory United States Date 23/10/24 Persons Charles Gerardo Title Ophirex Publishes Phase 2 Data in BMJ Global Health from the First Use of Varespladib to Treat Venomous Snakebite Victims Media name/outlet APNews.com Country/Territory United States Date 23/10/24 URL ct.moreover.com/?a=55100603333&p=1gw&v=1&x=B-Q8d1yUdHoPnINSW6PmzA Persons Charles Gerardo Title Ophirex Publishes Phase 2 Data in BMJ Global Health from the First Use of Varespladib to Treat Venomous Snakebite Victims Media name/outlet Le Lezard.com Country/Territory Canada Date 23/10/24 URL ct.moreover.com/?a=55100644040&p=1gw&v=1&x=8ldo8KhF861PwU-qNMxTIw Persons Charles Gerardo